LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11010-021-04335-7.pdf
Reference36 articles.
1. Horvat M, Zadnik V, Juznic Setina T, Boltezar L, Pahole Golicnik J, Novakovic S, Jezersek Novakovic B (2018) Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone. Oncol Lett 15:3602–3609. https://doi.org/10.3892/ol.2018.7774
2. Yin X, Xu A, Fan F, Huang Z, Cheng Q, Zhang L, Sun C, Hu Y (2019) Incidence and mortality trends and risk prediction nomogram for extranodal diffuse large B-cell lymphoma: an analysis of the surveillance, epidemiology, and end results database. Front Oncol 9:1198. https://doi.org/10.3389/fonc.2019.01198
3. Nowakowski GS, Czuczman MS (2015) ABC, GCB, and double-hit diffuse large B-cell lymphoma: does subtype make a difference in therapy selection? Am Soc Clin Oncol Educ Book. https://doi.org/10.14694/EdBook_AM.2015.35.e449
4. Rovira J, Valera A, Colomo L, Setoain X, Rodriguez S, Martinez-Trillos A, Gine E, Dlouhy I, Magnano L, Gaya A, Martinez D, Martinez A, Campo E, Lopez-Guillermo A (2015) Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy. Ann Hematol 94:803–812. https://doi.org/10.1007/s00277-014-2271-1
5. Kubuschok B, Held G, Pfreundschuh M (2015) Management of diffuse large B-cell lymphoma (DLBCL). Cancer Treat Res 165:271–288. https://doi.org/10.1007/978-3-319-13150-4_11
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review;Frontiers in Immunology;2024-08-27
2. The PVT1, HULC, and HOTTIP expression changes due to treatment in Diffuse Large B-cell lymphoma;2024-08-07
3. Noncoding RNAs in B cell non-Hodgkins lymphoma;Gene;2024-07
4. RPRD1B/CREPT facilitates the progression of diffuse large B-cell lymphoma by inhibiting apoptosis through the NF-κB signaling pathway;Asian Pacific Journal of Tropical Biomedicine;2024-07
5. PGM5-AS1 Promotes Progression of Diffuse Large B-Cell Lymphoma and Immune Escape by Regulating miR-503-5p;Journal of Inflammation Research;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3